Presentation TCT 2015

Should FFR Be Used Routinely in STEMI Patients With Multivessel Disease, and Is It Reliable During the Index and/or Staged Procedures?

Presenter: Colin Berry

October 11, 2015

Presentation

TCT 2015

Presentation TCT 2015

Debate 2: Should Long-term (2 Years to Life) Dual Antiplatelet Therapy Be Used in Most Patients After MI? Yes, and the Data Are Strong for Ticagrelor (PEGASUS Trial)!

Presenter: Neal S. Kleiman

October 11, 2015

Presenter: Michael A. Kutcher

October 11, 2015

Presentation TCT 2013

Presenter: Emmanouil Brilakis

October 31, 2013